To the Editor: We read the paper by Ramsay et al.~ with great interest since it contains information that may support a clinical impression that we have formed in our use of nalbuphine over the past two years. They describe a sympathetic response when nalbuphine was given to their intubated patients a few hours after fentanyl-supplemented general anaesthesia. We have also sometimes observed an increase in blood pressure and heart rate after 0.05 to 0.1 mg.kg-t of nalbuphine administration at emergence from fentanyl-supplemented anaesthesia. Such a "sympathetic response" has "also been reported by others 2-4
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However, contrary to the earlier authors who attribute that response to the reversal of analgesia by nalbuphine, it has been our impression that it has related to the presence of the endotracheal tube in the trachea of our patients. Ramsay et al. present data that may support that hypothesis rather than the reversal of analgesia by nalbuphine. All but three of their patients stabilised after extubation and"did not require more analgesia in the following 12 hours than those who did not receive the drug." Furthermore, it seems that the three patients who required morphine and sedation where those who remained intubated. We believe that these three patients might also have "settled down" and stabilised if they had been extubated since they were likely responding to the presence of the endotracheal tube rather than suffering from incisional pain.
Martin et al. showed that low dose fentanyl blunts circulatory responses to tracheal intubation. They suggested that fentanyl blunts the response to laryngeal stimulation by its agonistic activity at the opioid receptors, as found by Atweh and Kuhar 6 in the solitary nuclei and the nuclei of the ninth and tenth cranial nerves. They believed that these opioid receptors were associated with visceral afferent fibres of these nerves which originate in the pharynx and larynx.
We propose that nalbuphine may have a low degree of intrinsic activity, or an antagonistic activity, at these receptor sites. Furthermore, even though the subtype of these opioid receptors found by Atweh and Kuhar is still unknown, we propose that they are of the same subtype as those responsible for the respiratory depression and/or pruritus, since nalbuphine has been shown to have an antagonistic activity at these receptors subtypes. 7's These have yet to be identified as being mu,, mu2, sigma, delta, epsilon or another subtype.
Our hypothesis deserves further study since the possibility of nalbuphine reversing opioid-induced obtundation of laryngeal reflexes while preserving analgesia could have significant clinical advantages. Our patient was a 45-year-old female who underwent three operations for dissecting aneurysm and pituitary tumour during a nine month period. During each of the three anaesthetics she developed anaphylactoid reactions including an urticaria-like skin rash and arterial hypotension (<60mmHg systolic) following the administration of different anaesthetic agents. Based upon the time course of these events, 0.5 per cent lidocaine used for skin analgesia was suspected as a causative factor in the first event; 4.0 per cent lidocaine spray, which was administrated into the larynx and trachea, was suspected as a causative factor in the second; and in the third event, fentanyl was primarily suspected to have caused the anaphylactoid reaction.
It was later discovered that each of the preparations of the three drugs contain methylparaben as a preservative, Although methylparaben allergy has not been previously proven by several tests, including the intradermal test and the Prausnitz-KiJstner test, this preservative was strongly suspected as a causative agent in our patient.
Stoelting 2 and Moudgil 3 suspect that anaphylaxis to local anaesthetics and muscle relaxants is mainly due to reaction to methylparaben. Swanson 4 proposed using small test doses (0.1 ml) of pure
